Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.

Mihaly KoltaiJocelyn MoyesBryan NyawandaJoyce NyiroPatrick K MunywokiStefano TempiaXiao LiMarina AntillonJoke BilckeStefan FlaschePhilippe BeutelsD James NokesCheryl CohenMark Jit

Published in: BMC medicine (2023)

Incorporation of new data indicating the disease burden is highly concentrated in the first 6 months of life in two African settings suggests that interventions against RSV disease may be more cost-effective than previously estimated.

Keyphrases

respiratory syncytial virus
south africa
physical activity
electronic health record
big data
birth weight
pregnant women
machine learning
data analysis
pregnancy outcomes
risk factors
preterm birth